Your AI-Trained Oncology Knowledge Connection!

Video

Advice for Community Oncologists Treating Patients With R/R MM

Author(s):

Brea Lipe, MD,Peter Forsberg, MD

Drs Lipe and Forsberg share advice for community oncologists and highlight unmet needs in the management of multiple myeloma.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!
Related Videos
Dr Zonder on the Need for Increased Awareness in Multiple Myeloma
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
Alfred L. Garfall, MD
Joshua Richter, MD of Tisch Cancer Institute
Guenther Koehne, MD, deputy director and chief of Stem Cell Transplantation, Hematologic Oncology and Benign Hematology at Miami Cancer Institute, Baptist Health South Florida
Related Content
The top 5 OncLive videos of the week cover insights in gynecologic cancer, multiple myeloma, urothelial cancer, MPNs, and prostate cancer.
March 23rd 2025

Five Under 5: Top Oncology Videos for the Week of 3/16

Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS
May 23rd 2024

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

The top 5 OncLive videos of the week cover insights in colorectal cancer, myeloma, HER2+ breast cancer, and KRAS G12X+ pancreatic ductal adenocarcinoma.
March 16th 2025

Five Under 5: Top Oncology Videos for the Week of 3/9

Paul G. Richardson, MD
October 2nd 2023

Richardson Reviews Findings and Future Directions With Mezigdomide Plus Dexamethasone in R/R Myeloma

Image Credit:© LASZLO– stock.adobe.com
February 28th 2025

CHMP Recommends Subcutaneous Daratumumab Plus VRd for Newly Diagnosed Myeloma

Multiple Myeloma | Image credit: © Nittaya – stock.adobe.com
February 28th 2025

CHMP Recommends Conditional Approval of Linvoseltamab for R/R Multiple Myeloma